20 year followup on high-dose chemo with HSCT in high-risk breast cancer

The Circulating Cell-Free Genome Atlas Study

Updates from the EMBRACA trial for advanced breast cancer

Comment on the Every Woman Study

Therapeutic targeting at a pre-metastatic stage for brain metastases from lung cancer

Recent advances in CNS tumour management

Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer

Updates in head and neck cancers

KEYNOTE022: Triplet therapy for BRAF melanoma

First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma

SPLENDOUR: Added denosumab in first line adv NSCLC treatment

Cisplatin superior to cetuximab for HPV oropharyngeal cancer